31
Participants
Start Date
March 11, 2018
Primary Completion Date
June 27, 2019
Study Completion Date
June 27, 2019
Omnigen
For those randomised onto the investigational arm, a dual layer of the Omnigen product will be applied at baseline and at every fortnightly trial visit until healing or the end of the 12 week period whichever occurs first, according to the standard study procedure.
Dummy Packaging
For those randomised into the control arm, dummy packaging will be opened at the time of application of standard of care, to ensure the same experience is received to those on the experiential arm.
University Hospitals Derby and Burton, Royal Derby Hospital, Derby
University of Nottingham Teachig Hospitals, City Hospital, Nottingham
Collaborators (1)
NuVision Biotherapies Ltd
UNKNOWN
University Hospitals of Derby and Burton NHS Foundation Trust
OTHER